J&J | JNJ - Action





Action Changement Date
AbbVie USD 5.05B 98M 2026-03
Abbott USD 6.99B 501M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
Baxter International USD 2.32B 84M 2026-03
Bayer EUR 12.34B 3M 2025-12
Becton, Dickinson and Co. USD 3.36B 728M 2026-03
Biogen USD 1.95B 219.1M 2026-03
Boston Scientific USD 3.12B 174M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
CONMED USD 366.11M 10.56M 2026-03
Cooper Companies USD 876.4M 30.4M 2025-12
Dexcom USD 693.6M 64.5M 2026-03
Edwards Lifesciences USD 1.12B 7.2M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Globus Medical USD 772.6M 13.32M 2026-03
Insulet USD 462.5M 9.9M 2026-03
Integra LifeSciences USD 495.04M 2.3M 2026-03
Intuitive Surgical USD 1.95B 105.1M 2026-03
J&J USD 14.58B 392M 2026-03
Medtronic USD 6.31B 153M 2025-12
Merck USD 6.48B 179M 2026-03
Merit Medical Systems USD 352.39M 18.68M 2026-03
Novartis USD 6.29B 17M 2026-03
Pfizer USD 10.67B 13M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Stryker USD 5.42B 109M 2026-03
Tandem Diabetes Care USD 126.4M 2.37M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03
Zimmer Biomet Holdings USD 2.25B 39.6M 2026-03
Zoetis USD 2.55B 120M 2026-03